Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GateMOF

Financiado

Molecular gated Eco-MOFs for anti-cancer drug delivery

Cancer is a major societal challenge, as reflected by Horizon's Europe mission on cancer and Europe's Beating Cancer Plan. In particular, despite great advances in cancer treatment in recent decades, its treatment still remains a... ver más

04/02/2027

UPV

165K€

Presupuesto del proyecto: 165K€

Líder del proyecto

UNIVERSITAT POLITÈCNICA DE VALÈNCIA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 685

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-05-14

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 1 año

0% 100%

1 Participantes

UPV

165.31K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

TherACCage Therapeutic Artificial Cells based on Molecular Cages for Gl... 181K€ Cerrado

Enhanced-DDS An enhanced drug delivery system for brain cancer treatment... 148K€ Cerrado

BES-2015-075926 DESARROLLO DE NANOMATERIALES QUIMIOINMUNOTERAPEUTICOS PARA E... Cerrado

TheranoXome Engineered Exosomes for Stimuli-responsive Image-guided Drug... 181K€ Cerrado

CTQ2014-54004-P DISEÑO DE SISTEMAS DENDRITICOS AVANZADOS PARA SU USO EN BIOM... 123K€ Cerrado

CTQ2017-90050-R GLICO-NANOSISTEMAS MULTIVALENTES BASADOS EN METALES NOBLES Y... 80K€ Cerrado

Duración del proyecto: 32 meses Fecha Inicio: 2024-05-14
Fecha Fin: 2027-02-04

Líder del proyecto

UNIVERSITAT POLITÈCNICA DE VALÈNCIA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 685

Presupuesto del proyecto 165K€

Descripción del proyecto Cancer is a major societal challenge, as reflected by Horizon's Europe mission on cancer and Europe's Beating Cancer Plan. In particular, despite great advances in cancer treatment in recent decades, its treatment still remains a challenge without an effective cure. In 2020 the EU reported around 3 million new cancer cases and more than 1.2 million deaths, and its incidence is expected to increase in Europe due to its aging population. The standard treatment relies on the systemic administration of chemotherapeutics, which has limited efficacy and causes side effects. To overcome current limitations, GateMOF will develop low-toxicity Molecular Organic Frameworks (MOFs) as advanced nanosystems to tackle cancer. Such Eco-MOFs will be equipped with molecular gates and loaded with anticancer drugs resulting in advanced biocompatible nanosystems with the ability to respond to stimuli present in the tumor intracellular/microenvironment for a selective anticancer drug delivery. The project combines the unique expertise of the host laboratory (Supramolecular Chemistry and Biotechnology) and the candidate (MOF design and synthesis) to ensure the fulfillment of objectives. The fellow will be trained in advanced nanomaterial preparation with molecular gates to obtain stimuli-responsive MOFs for anti-cancer drug delivery, including training for biological studies for their evaluation in vitro in cells and in vivo in animal models. Notably, the project will also allow the fellow to gain experience in patenting and tech transfer. Altogether, GateMOF will develop a new therapeutic technology and provide the fellow with complementary scientific and transferable skills with a significant impact toward an independent research career.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores